| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-06 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-06 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-06 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.22 | 1e-05 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |